These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model. Malmstrom K; Fricke JR; Kotey P; Kress B; Morrison B Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285 [TBL] [Abstract][Full Text] [Related]
7. The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials. Morrison BW; Fricke J; Brown J; Yuan W; Kotey P; Mehlisch D J Am Dent Assoc; 2000 Dec; 131(12):1729-37. PubMed ID: 11143737 [TBL] [Abstract][Full Text] [Related]
9. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. Ott E; Nussmeier NA; Duke PC; Feneck RO; Alston RP; Snabes MC; Hubbard RC; Hsu PH; Saidman LJ; Mangano DT; ; J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1481-92. PubMed ID: 12830070 [TBL] [Abstract][Full Text] [Related]
11. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Joshi GP; Viscusi ER; Gan TJ; Minkowitz H; Cippolle M; Schuller R; Cheung RY; Fort JG Anesth Analg; 2004 Feb; 98(2):336-342. PubMed ID: 14742366 [TBL] [Abstract][Full Text] [Related]
12. Valdecoxib versus rofecoxib in acute postsurgical pain: results of a randomized controlled trial. Christensen KS; Cawkwell GD J Pain Symptom Manage; 2004 May; 27(5):460-70. PubMed ID: 15120774 [TBL] [Abstract][Full Text] [Related]
13. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial. Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. Moberly JB; Xu J; Desjardins PJ; Daniels SE; Bandy DP; Lawson JE; Link AJ; Truitt KE Clin Ther; 2007 Mar; 29(3):399-412. PubMed ID: 17577461 [TBL] [Abstract][Full Text] [Related]
15. The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery. Malan TP; Gordon S; Hubbard R; Snabes M Anesth Analg; 2005 Feb; 100(2):454-460. PubMed ID: 15673875 [TBL] [Abstract][Full Text] [Related]
16. Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. Zuniga JR; Phillips CL; Shugars D; Lyon JA; Peroutka SJ; Swarbrick J; Bon C J Oral Maxillofac Surg; 2004 Jul; 62(7):806-15. PubMed ID: 15218558 [TBL] [Abstract][Full Text] [Related]
17. A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy. Bikhazi GB; Snabes MC; Bajwa ZH; Davis DJ; LeComte D; Traylor L; Hubbard RC Am J Obstet Gynecol; 2004 Oct; 191(4):1183-91. PubMed ID: 15507939 [TBL] [Abstract][Full Text] [Related]